The Danish Medicines Agency has issued a report on the risk of thrombosis in oral contraceptive users
- PDF / 136,237 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 28 Downloads / 153 Views
1
■ The Danish Medicines Agency has issued a report on the risk of thrombosis in oral contraceptive users recommending that second generation pills (containing norgestrel, levonorgestrel or norgestimate) be prescribed where possible. A review of the literature and analysis of data on oral contraceptive use and adverse events reports in Denmark found that the overall risk of thrombosis in oral contraceptive users is low, with first and second generation pills having the lowest risk, and that summaries of product characteristics and package leaflets included the most recent safety information. Third generation oral contraceptives (containing desogestrel or gestodene) are most frequently used by Danish women, and are most likely to be prescribed to first-time users. Danish Medicines Agency. New report from the Danish Medicines Agency about the use of contraceptive pills and risk of thrombosis. Danish Pharmacovigilance Update 3: 6, No. 2, 16 Feb 2012. Available from: URL: 803068227 http://laegemiddelstyrelsen.dk/
0114-9954/10/1394-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved
Reactions 24 Mar 2012 No. 1394
Data Loading...
